David Claveau

Background

About David Claveau

David is a seasoned healthcare executive with a strong background in the drug development industry, spanning from drug discovery to commercialization. Known for his scientific expertise complemented by business acumen, David is driven by a passion to create a meaningful impact through collaboration, strategic thinking, and unlocking the potential of individuals and situations. Currently, David holds the position of Vice-President, Business Development, North America at Sygnature Discovery, a reputable Contract Research Organization (CRO) specializing in pre-clinical integrated drug discovery services. In this role, he plays a key part in driving business growth and establishing valuable partnerships. With his insightful leadership and extensive industry knowledge, David contributes to the success of Sygnature Discovery, helping to deliver innovative solutions and support the advancement of cutting-edge therapies. Previously, David held notable positions within the pharmaceutical sector. He led business intelligence initiatives at Ventus Therapeutics, a biotech company headquartered in Montreal and Boston. During his time there, he focused on driving advancements in immunology, neuroscience, and oncology diseases. David's strategic insights and commitment to progress contributed to the company's success in developing transformative treatments. Before joining Ventus Therapeutics, David served as a leader in medical affairs and medical information at AVIR Pharma, a Quebec-based pharmaceutical firm specializing in licensing and facilitating access to innovative medicines for Canadian patients. His dedication to delivering high-quality care and patient-centric initiatives left a positive impact on the organization, enhancing the availability of life-changing treatments. David's career began at the Merck Frosst Therapeutic Centre, where he started as a biochemist. Throughout his tenure, he showcased his scientific expertise and gradually assumed roles of increasing responsibility within the biology department, contributing to the advancement of key projects. With his ability to bridge scientific innovation and business strategy, David Claveau continues to be an influential figure in the healthcare industry. His commitment, collaborative mindset, and experience empower organizations to make a meaningful impact on patient care and well-being.